Oventus Medical

Oventus is an Australian medical device company and is listed on the Australian Securities Exchange (ASX: OVN). We offer a new treatment modality for obstructive sleep apnoea (OSA) via our Airway Technology. We are committed to providing the highest quality corporate governance and the generation of sustainable, long-term returns for our shareholders. Our mission is to be a global leader in the treatment of snoring and OSA. What makes us unique is our patented airway design, allowing for breathing through our O2VentTM oral devices to bypass obstructions of the nose, soft palate and tongue that can contribute to snoring and OSA. The O2VentTM is bridging the gap between Oral Appliance and CPAP therapy to enhance treatment outcomes, including for CPAP intolerant sleep apnoea sufferers.  

Latest Media Releases

Oventus Announce R&D Tax Rebate received

06/11/2019 15:39:00

R&D Tax rebate received Brisbane, Australia 6th November 2019: Oventus Medical Ltd (ASX: OVN) is pleased to announce that is has received a cash refund of $828,000 from the Australian Taxation Of…

Oventus Announce AGM dial in details

01/11/2019 10:15:00

Brisbane, Australia 1 November 2019: Oventus Medical Ltd or the Company (ASX: OVN) is pleased to invite shareholders to participate in the 2019 Annual General Meeting (AGM) via a dial-in facility, to …

Latest News